SCHEMBL13458538

SCHEMBL13458538

Nc1ccccc1NC(=O)/C=C/c1ccc(C(CCCN2C[C@@H]3CC2CO3)C(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 14/20 0.49
▸ HDAC3 O15379 7/20 0.49
▸ HDAC2 Q92769 7/20 0.49
▸ CYP1A2 P05177 5/20 0.49
▸ CYP3A4 P08684 5/20 0.49
▸ CYP2D6 P10635 5/20 0.49
▸ CYP2C9 P11712 5/20 0.49
▸ CYP2C19 P33261 5/20 0.49
▸ KCNH2 Q12809 4/20 0.49
▸ HDAC4 P56524 4/20 0.49
▸ HDAC10 Q969S8 3/20 0.49
▸ HDAC9 Q9UKV0 3/20 0.49
▸ HDAC5 Q9UQL6 3/20 0.49
▸ HDAC11 Q96DB2 2/20 0.49
▸ HDAC8 Q9BY41 1/20 0.41
▸ MEF2D Q14814 1/20 0.40
▸ KDM1A O60341 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ CCNC P24863 1/20 0.38
▸ CDK8 P49336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1966895 1.00 HDAC1 (0.49) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10039310 1.00 HDAC1 (0.49) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10039309 0.94 HDAC1 (0.44) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL13458756 0.94 HDAC1 (0.45) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10039313 0.93 HDAC1 (0.47) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10069093 0.93 HDAC1 (0.44) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10039334 0.92 HDAC1 (0.49) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL13458758 0.92 HDAC1 (0.49) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10039312 0.92 HDAC1 (0.44) HDAC1HDAC3HDAC2CYP1A2CYP3A4
SCHEMBL10069248 0.91 HDAC1 (0.56) HDAC1HDAC3HDAC2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010031708-A2 NOVEL ORTHO-AMINOANILIDES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 — — WO disclosed
Send feedback